At DAY 135- several groups demonstrated significant differences i

At DAY 135- several groups demonstrated significant differences including: between M MAP versus MAP + NP-51 (both L and K); similarly in females (F) in the same experimental groups were significantly different ‘*’ P ≤ 0.05;

there were also notable differences ‘#’ (P ≤ 0.05) between M and F in the experimental groups MAP + NP-51 (both L and K). At DAY 90 among F, there was a significant difference PF 01367338 ‘*’ (P ≤ 0.05) between MAP v. MAP + L-NP-51; between the sexes – F-MAP vs. M-MAP and M-MAP + L-NP-51. Animals that were infected with viable MAP (L-MAP) and viable or non-viable NP-51 (L or K NP-51) demonstrate less MAP viability at Day 90 compared to similar experimental conditions at Day 135 or Day 180; however there was no statistical difference between these differences at DAY 90. Concentrations of MAP in the large intestine were low. Additionally, there was no pathology associated with MAP infection in the intestinal tissues of animals infected with viable or non-viable MAP. These data demonstrate that there may be associations to sex in MAP www.selleckchem.com/products/Liproxstatin-1.html infectivity of the intestinal tissues; however, to elucidate a clear correlation, further experiments will be conducted. Figure

2 qRT-PCR Assay to Quantitate MAP Cells from Infected BALB/c Mouse Tissues. B: MAP Concentrations in Liver Tissues. Similar to data from large intestinal tissues, liver samples from MAP infected animals at Day 90 demonstrated the least concentration of cells from animals fed viable or non-viable

NP-51. Female mice infected with viable MAP and fed viable NP-51 demonstrated less CYTH4 cells compared to MAP infected animals at Day 90, 135,and 180- however these results were not significantly different. Day 135 Control animals were contaminated with MAP as evidenced by histopathology (granulomas identified in liver tissues) and in these data. At DAY 180- there was a significant difference ‘*’ (P ≤ 0.05) between the following: M with viable MAP compared to M infected with viable MAP and fed live NP- 51 -MAP + L-NP-51; between M and F with MAP + L-NP-51, ‘**’ ,(P ≤ 0.05); and also, between M with MAP + L-NP-51 versus MAP + K-NP-51, ‘#’ ,(P ≤ 0.05). Histopathology analysis of liver tissues from animals infected with viable or non-viable MAP demonstrated granulomas; additionally, infected animals fed viable or non-viable NP-51 demonstrated granulomas. Similar to those data described in the large intestine, we observed differences between the sexes in MAP infectivity of the liver; also similar to those previously described- further analysis must be conducted to determine the contributive significance of this difference.

Comments are closed.